BSX vs EBS
Boston Scientific Corp (BSX) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BSX and EBS stock pages for the full models.
Not investment advice.